Akero Therapeutics (AKRO) Misses Q3 EPS by 1c

Akero Therapeutics (NASDAQ: AKRO) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• MP Materials seen largely insulated after China export-control move